Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about m6A RNA Modification: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| Lewy-body-like aggregation | modulates | phenotype | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Huntington's Disease | downregulates | disease | 0.85 |
| TDP-43 | associated_with | protein | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| m6A RNA Modification as Address Code for Granule Targeting | 0.700 | neurodegeneration | What determines the specificity of RNA-p |
| m6A-dependent control of alpha-synuclein transcript fate and | 0.626 | neurodegeneration | m6A RNA Modification and Alpha-Synuclein |
| Cell-state stratification is required to resolve m6A RNA Mod | 0.612 | neurodegeneration | m6A RNA Modification and Alpha-Synuclein |
| Perturbation-first validation should precede therapeutic cla | 0.608 | neurodegeneration | m6A RNA Modification and Alpha-Synuclein |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-27 | 4 hypotheses Top: 0.662
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning m6A RNA Modification in their description or question text
No additional research found